Ram Mandalam, PhD
Founder & Chief Executive Officer
We offer comprehensive Cell and Gene Therapy (CGT) drug development consulting services in the areas of preclinical development (proof-of-concept and IND-enabling studies), manufacturing (process development, scale-up, contract manufacturing), quality systems (QA/QC), regulatory and commercialization strategies. With over 150 years of combined experience, our team augments yours to efficiently accelerate your projects from discovery to market.
REQUEST CONSULTATIONEmpower your company with expert-led solutions by optimizing technical operations, business strategy, and preclinical development for maximum impact.
Advancing our clients’ cell and gene therapies to patients rapidly and efficiently by providing deep scientific, technical, and business expertise.
REQUEST CONSULTATION